trending Market Intelligence /marketintelligence/en/news-insights/trending/8ybmgci1tjmbrhqvsrcbqw2 content esgSubNav
In This List

XBiotech names director

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


XBiotech names director

XBiotech Inc. elected Donald MacAdam as a board member.

MacAdam is currently a director of Hammond Power Solutions Inc. and has previously served as CEO of MBVax Bioscience Inc.

Austin, Texas-based XBiotech develops antibodies for treating diseases such as cancer, inflammatory conditions and vascular diseases.